Real-World Prognostic & Predictive Implications of EORTC & MRS Scores for Immunotherapy and Chemotherapy in Pleural Mesothelioma (PM)

被引：0
|
作者：
Wu, F. T. H. [1 ,2 ]
D'Amours, M. -F. [1 ]
Usman, F. [1 ]
Hussein, A. [1 ]
Bhang, E. [1 ]
Sarvestani, M. Kamali [1 ]
Lee, C. W. [2 ,3 ]
Ho, C. [1 ,2 ]
机构：
[1] BC Canc Vancouver Ctr, Vancouver, BC, Canada
[2] Univ British Columbia, Vancouver, BC, Canada
[3] BC Canc Surrey Ctr, Surrey, BC, Canada
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期
关键词：
pleural mesothelioma; prognostic; predictive;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P4.14C.03
引用
收藏
页码：S409 / S409
页数：1
相关论文
共 50 条
  • [11] Immunotherapy Toxicities in Real-World Use of Nivolumab & Ipilimumab in Pleural Malignant Mesothelioma: Experience from Sussex Cancer Centre
    Lonn, Cheung
    Zaki, Kam
    Donovan, Victoria
    Kanlal, Kavita
    LUNG CANCER, 2024, 190
  • [12] The Role of Real-World Evidence to Support Treatment Choices in Malignant Pleural Mesothelioma
    Wheatley-Price, Paul
    Moore, Sara
    Lee, Christopher W.
    JTO CLINICAL AND RESEARCH REPORTS, 2022, 3 (04):
  • [13] Real-world outcomes for patients with pleural mesothelioma: A multisite retrospective cohort study
    Chow, Kar Ven Cavan K. V. C. C.
    Turner, CassieC. T.
    Hughes, BrettB. H.
    Houston, Kathleen K. H.
    Lwin, Zarnie Z. L.
    Chan, Bryan B. C.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 : 159 - 159
  • [14] Real-world outcomes for patients with pleural mesothelioma: A multisite retrospective cohort study
    Chow, Kar Ven Cavan
    Turner, Cassie
    Hughes, Brett
    Houston, Kathleen
    Lwin, Zarnie
    Chan, Bryan
    RESPIROLOGY, 2023, 28 : 25 - 25
  • [15] Real-world outcomes for patients with pleural mesothelioma: A multisite retrospective cohort study
    Chow, Kar Ven Cavan
    Turner, Cassie
    Hughes, Brett
    Lwin, Zarnie
    Chan, Bryan
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2024, 20 (06) : 723 - 730
  • [16] Immune Checkpoint Inhibitor Uptake in Real-World Patients With Malignant Pleural Mesothelioma
    Kim, Roger Y.
    Mitra, Nandita
    Bagley, Stephen J.
    Marmarelis, Melina E.
    Haas, Andrew R.
    Rendle, Katharine A.
    Vachani, Anil
    JTO CLINICAL AND RESEARCH REPORTS, 2021, 2 (06):
  • [17] Multimodal Treatment of Malignant Pleural Mesothelioma: Real-World Experience with 112 Patients
    Holzknecht, Arnulf
    Illini, Oliver
    Hochmair, Maximilian J.
    Krenbek, Dagmar
    Setinek, Ulrike
    Huemer, Florian
    Bitterlich, Erwin
    Kaindl, Christoph
    Getman, Vladyslav
    Akan, Ahmet
    Weber, Michael
    Leobacher, Gunther
    Valipour, Arschang
    Mueller, Michael R.
    Watzka, Stefan B.
    CANCERS, 2022, 14 (09)
  • [18] Real-world use of systemic therapy in elderly patients with malignant pleural mesothelioma (MPM)
    Cedres, S.
    Assaf, J. D.
    Iranzo, P.
    Callejo, A.
    Pardo, N.
    Navarro, A.
    Martinez-Marti, A.
    Rodriguez, G.
    Monton, V.
    Gonzalo, J.
    Miquel, J. M.
    Pedrola, A.
    Dienstmann, R.
    Felip, E.
    ANNALS OF ONCOLOGY, 2019, 30
  • [19] Immune checkpoint inhibitors in the treatment of pleural mesothelioma: insights from real-world data
    Kanayama, Masatoshi
    Manabe, Takehiko
    Yoshimatsu, Katsuma
    Oyama, Rintaro
    Matsumiya, Hiroki
    Mori, Masataka
    Takenaka, Masaru
    Kuroda, Koji
    Tanaka, Fumihiro
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2025, : 705 - 717
  • [20] Real-World Survival Outcomes of Patients with Malignant Pleural Mesothelioma by Physician's Choice of First-line Platinum Chemotherapy
    Kerrigan, K.
    Chipman, J.
    Jo, Y. J.
    Haaland, B.
    Johnson, E.
    Puri, S.
    Varghese, T.
    Akerley, W.
    Patel, S.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S122 - S123
12345